|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
2
|
Resverlogix Corp.
|
Jan 14, 2019 06:35PM
|
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
1
|
Resverlogix Corp.
|
Jan 14, 2019 06:18PM
|
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
2
|
Resverlogix Corp.
|
Jan 14, 2019 04:21PM
|
|
Re: Deadlines missed? Results Late? Not really.
|
1
|
Resverlogix Corp.
|
Jan 12, 2019 04:51PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 03:45PM
|
|
New price level when they announce 250 MACE Events,...?
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 11:31AM
|
|
Re: Biotech Showcase Presentation is up
|
3
|
Resverlogix Corp.
|
Jan 07, 2019 10:45PM
|
|
Re: Biotech Showcase Presentation is up
|
3
|
Resverlogix Corp.
|
Jan 07, 2019 08:11PM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 05, 2019 08:30PM
|
|
Re: Revamped website
|
11
|
Resverlogix Corp.
|
Jan 05, 2019 06:09PM
|
|
Re: 1,300 warrants traded in all of December....
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 02:37PM
|
|
Re: NASH is a $35 Billion US/year market
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 10:21AM
|
|
Re: NASH is a $35 Billion US/year market
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 09:49AM
|
|
We held up well again today,..
|
3
|
Resverlogix Corp.
|
Dec 24, 2018 12:59PM
|
|
Re: Holding steady
|
3
|
Resverlogix Corp.
|
Dec 22, 2018 02:44PM
|
|
Re: Coronary Artery Calcium Score
|
4
|
Resverlogix Corp.
|
Dec 21, 2018 11:20AM
|
|
Is this important,..
|
2
|
Resverlogix Corp.
|
Dec 19, 2018 05:21PM
|
|
Re: Difference between DSMB #7 and DSMB #8
|
1
|
Resverlogix Corp.
|
Dec 19, 2018 04:24PM
|
|
8th positive safety review out this morning
|
2
|
Resverlogix Corp.
|
Dec 19, 2018 08:54AM
|
|
Re: Tick tock
|
3
|
Resverlogix Corp.
|
Dec 15, 2018 07:59AM
|
